Interleukin-17 and T Helper 17 Cells in Mucosal Immunity of the Lung

QR Code

Interleukin-17 and T Helper 17 Cells in Mucosal Immunity of the Lung

None

Saved in:

Bibliographic Details
Main Authors:	Paats, M.S., Hal, P.Th.W. van, Baan, C.C., Hoogsteden, H.C., Eerden, M.M. van der, Hendriks, R.W.
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/30255
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Roles of Interleukin-17 and T Helper 17 Cells in Intestinal Barrier Function
by: Trusevych, Elizabeth, et al.
Published: (2012)

Molecular aspects of the T-helpers type 17 functioning
by: I. V. Kologrivova, et al.
Published: (2011-08-01)

The role of the T helper 17 and T regulatory cell ratio in the gut-thyroid axis
by: Julia Williams, et al.
Published: (2025-12-01)

ANALYSIS OF T HELPER SUBPOPULATIONS (Th1, Th2, Treg, Th17, ACTIVATED T-HELPERS) BY MEANS OF FLOW CYTOMETRY
by: S. V. Khaidukov, et al.
Published: (2014-07-01)

Features of interleukin-17 and interleukin-23 expression in patients with inflammatory bowel diseases
by: Yu.M. Stepanov, et al.
Published: (2025-03-01)

Lipoprotein(a) concentration and the blood content of INFγ-producing T-helpers 17 (Th17/1) in males with premature coronary artery disease
by: A. Yu. Filatova, et al.
Published: (2022-07-01)

Structural and functional characteristics of the T helpers 17 subpopulation in allergic diseases of the respiratory organs in children
by: E. V. Prosekova, et al.
Published: (2020-01-01)

Interleukin‐6 receptor alpha and CD27 discriminate intratumoral T helper 17 subpopulations with distinct functional properties in a mouse lung cancer model
by: Chong Liu, et al.
Published: (2021-12-01)

The role of interleukin 17 in the pathogenesis of rheumatoid arthritis. Are there any prospects for the use of IL-17 inhibitors?
by: E. L. Nasonov, et al.
Published: (2023-04-01)

Sarcoidosis clinical picture governs alterations in type 17 T helper cell subset composition and cytokine profile
by: N. M. Lazareva, et al.
Published: (2023-06-01)

New areas of the pharmacotherapy of rheumatic diseases are inhibition of interleukin-6 and interleukin-17
by: Evgeny Lvovich Nasonov
Published: (2013-10-01)

Effects of glycodelin on CCR6<sup>+</sup> cell subpopulations of Th17-polarized helper T cells
by: V. P. Timganova, et al.
Published: (2023-11-01)

T-helper Type 17 and Regulatory T-cell Profiles in Renal Allograft Recipients with Calcineurin Inhibitor Toxicity
by: Ravi Shankar Kushwaha, et al.
Published: (2025-04-01)

Fine-tuning immunity: ubiquitin-dependent regulation of interleukin-17A expression by Th17 cells
by: Desh Raj, et al.
Published: (2025-08-01)

The Pivotal Role of Interleukin-17 in the Pathogenesis of Systemic Lupus Erythematosus
by: Duaa Sami Segatri, et al.
Published: (2025-06-01)

Course of uveitis in patients with ankylosing spondylitis during the interleukin 17 inhibitors therapy
by: A. A. Godzenko, et al.
Published: (2023-10-01)

The role of interleukin 17 in the pathogenesis of giant cell arteritis: new possibilities for pharmacotherapy
by: E. L. Nasonov, et al.
Published: (2024-12-01)

Real‐World Data on the p.Gly17Val RHOA Mutation in Diagnosing T Follicular Helper Cell Lymphomas
by: Yuri Tsuboi, et al.
Published: (2025-05-01)

Successful use of the interleukin-17A inhibitor (ixekizumab) in the treatment of psoriatic arthritis
by: A. M. Dadalova, et al.
Published: (2020-11-01)

Inhibitors of interleukin 17A in the treatment of psoriatic arthritis: what's new?
by: Т. V. Korotaeva
Published: (2021-04-01)

Comparative pharmacoeconomic effectiveness of interleukin-17 inhibitors for the treatment of ankylosing spondylitis
by: T. V. Dubinina, et al.
Published: (2022-12-01)

Value of polymorphism of a gene of interleukin-17 (П-17а g-197a, il-17f his161arg) in a pathogenesis of the influenza IN children
by: N. A. Miromanova
Published: (2013-11-01)

INTERLEUKIN-17A IS A NEW TARGET OF ANTICYTOKINE THERAPY FOR ANKYLOSING SPONDYLITIS
by: Sh. F. Erdes
Published: (2016-09-01)

The efficacy of the interleukin 17 inhibitor ixekizumab in psoriatic arthritis: data from real clinical practice
by: I. M. Marusenko, et al.
Published: (2021-06-01)

INTERLEUKIN-17 IS A NEW TARGET FOR ANTI-CYTOKINE THERAPY OF IMMUNE INFLAMMATORY RHEUMATIC DISEASES
by: Evgeny Lvovich Nasonov, et al.
Published: (2013-12-01)

NEW POSSIBILITIES OF PHARMACOTHERAPY FOR IMMUNOINFLAMMATORY RHEUMATIC DISEASES: A FOCUS ON INHIBITORS OF INTERLEUKIN-17
by: E. L. Nasonov
Published: (2017-03-01)

Predictive Significance of Interleukins 17A and 33 in Risk of Relapsing–Remitting Multiple Sclerosis
by: Milad Abdul Salam Al-Naseri, et al.
Published: (2022-12-01)

Efficacy of interleukin-17 inhibitors in psoriasis patients: a comparative non-randomized study
by: Arfenya E. Karamova, et al.
Published: (2025-06-01)

Serum interleukin-17 expression in postmenopausal women and its relation to osteoporosis and risk of fractures
by: Samar G. Soliman, et al.
Published: (2025-01-01)

A case of psoriasis and atopic dermatitis-like rash induced by interleukin-17 and interleukin-23 inhibitors successfully controlled with upadacitinib
by: Toshiki Okazaki, MD, et al.
Published: (2025-09-01)

SUCCESSFUL USE OF AN INTERLEUKIN 17 INHIBITOR (SECUKINUMAB) IN THE TREATMENT OF ISOLATED DESTRUCTIVE ENTHESITIS IN PSORIATIC ARTHRITIS
by: E. E. Gubar, et al.
Published: (2018-11-01)

Overexpression of Interleukin-17 Modulates Responses to Marek’s Disease Virus Infection and Tumor Formation in Chickens
by: Nitish Boodhoo, et al.
Published: (2025-07-01)

Molecular mechanism of Haikun Shenxi Capsules as adjuvant therapy for diabetic kidney disease through the interleukin-23/interleukin-17 inflammatory axis
by: Zhang An-na, et al.
Published: (2025-06-01)

PROSPECTS FOR USING INTERLEUKIN-17 INHIBITORS, A NEW CLASS OF DRUGS FOR TARGETED THERAPY OF PSORIATIC ARTHRITIS
by: T. V. Korotaeva
Published: (2016-07-01)

Serum levels of interleukin-17, -18, -22, and -25 in patients with bullous pemphigoid before and after treatment
by: Xinyi Hong, et al.
Published: (2025-07-01)

Immune control of the basal ganglia network: Interleukin-17 as a key modulator of striatal synaptic plasticity
by: Andrea Mancini, et al.
Published: (2025-09-01)

Assessing the relative efficacy of interleukin-17 and interleukin-23 targeted treatments for moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis of PASI response.
by: Laura M Sawyer, et al.
Published: (2019-01-01)

RNAI-MEDIATED SILENCING OF MATRIX METALLOPROTEINASE 1 IN EPIDERMAL KERATINOCYTES INFLUENCES THE BIOLOGICAL EFFECTS OF INTERLEUKIN 17A
by: J. A. Mogulevtseva, et al.
Published: (2018-07-01)

Interleukin 17 as a central component of the pathogenesis of pain associated with immunoinflammatory process: A new “target” of pharmacotherapy
by: А. Е. Karateev, et al.
Published: (2024-04-01)

The prognostic value of interleukin-17 in lung cancer: A systematic review with meta-analysis based on Chinese patients.
by: Xiao-Fei Wang, et al.
Published: (2017-01-01)